Current Message	Return to posts
From: Hamsterwheel
Imagine a technology so advanced it engineers the immune system to hunt cancer with ruthless precision. $NWBO’s aDC1 platform—25 years in the making—is doing just that, treating dying patients RIGHT NOW in Phase 2 trials backed by $25.7M in federal funding. This isn’t just immunotherapy it’s a revolution that turns “cold,” untreatable tumors into “hot,” vulnerable targets. With potential to boost response rates from 20% to 40-60%+, it could double the $30B+ market. Buckle up—let’s dive into a breakthrough that’s rewriting cancer’s rules

Current Thread	Author	Time
Imagine a technology so advanced it engineers the immune system to hunt cancer with ... [more]	Hamsterwheel	17:28:45

You must log in or register before you can post messages (you'll be returned to this page once logged in).